127
Views
6
CrossRef citations to date
0
Altmetric
Review

Treating malignant glioma in Chinese patients: update on temozolomide

, , &
Pages 235-244 | Published online: 12 Feb 2014

References

  • ZhouLFWangRZBaoSDChinese guideline for diagnosis and treatment on central nervous system tumorsZhonghua Yi Xue Za Zhi20129223092313 Chinese
  • HuseJTHollandECTargeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastomaNat Rev Cancer20101031933120414201
  • YinLZhangLCorrelation between MRI findings and histological diagnosis of brainstem gliomaCan J Neurol Sci20134034835423603170
  • Di StefanoALEnciso-MoraVMarieYAssociation between glioma susceptibility loci and tumour pathology defines specific molecular etiologiesNeuro Oncol20131554254723161787
  • OhgakiHKleihuesPGenetic alterations and signaling pathways in the evolution of gliomasCancer Sci20091002235224119737147
  • YangPWangYPengXManagement and survival rates in patients with glioma in China (2004–2010): a retrospective study from a single-institutionJ Neurooncol201311325926623483435
  • ChenCXuTLuYThe efficacy of temozolomide for recurrent glioblastoma multiformeEur J Neurol20132022323022680781
  • StrikHMMarosiCKainaBTemozolomide dosing regimens for glioma patientsCurr Neurol Neurosci Rep20121228629322437507
  • WuJSZhangJZhuangDXCurrent status of cerebral glioma surgery in ChinaChin Med J (Engl)20111242569257722040405
  • QiuTMYaoCJWuJSClinical experience of 3T intraoperative magnetic resonance imaging integrated neurosurgical suite in Shanghai Huashan HospitalChin Med J (Engl)20121254328433323253696
  • WangJLiuXBaYMEffect of sonographically guided cerebral glioma surgery on survival timeJ Ultrasound Med20123175776222535723
  • WuJSGongXSongY142 3.0T iMRI guided resection in cerebral glioma surgery: interim analysis of a prospective, randomized, triple-blind, parallel-controlled trialNeurosurgery201360Suppl167
  • PichlmeierUBinkASchackertGResection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patientsNeuro Oncol2008101025153418667747
  • WangLTuQZhouWEfficacy and safety of 3-dimensional conformal radiotherapy combined with temozolomide for gliomaZhong Nan Da Xue Xue Bao Yi Xue Ban20113611061110 Chinese22169729
  • ZhaiXWangJZhangJComparison of two regimens of postoperative concurrent chemoradiotherapy in adult patients with grade III–IV cerebral gliomasNan Fang Yi Ke Da Xue Xue Bao201232255257 Chinese22381771
  • MaXLvYLiuJSurvival analysis of 205 patients with glioblastoma multiforme: clinical characteristics, treatment and prognosis in ChinaJ Clin Neurosci2009161595160819793663
  • WangZGYangWDYangSYA clinical effect of temozolomide in patients with malignant gliomaJournal of Tianjin Medical University200814148151 Chinese
  • SaiKYangQYShenDChemotherapy for gliomas in mainland China: an overviewOncol Lett201351448145223761809
  • WangYChenXZhangZComparison of the clinical efficacy of temozolomide (TMZ) versus nimustine (ACNU)-based chemotherapy in newly diagnosed glioblastomaNeurosurg Rev201437737823912878
  • YaoCXZhangSPChenBClinical effect of intensity modulated radiation therapy combined with concomitant and adjuvant temozolomide in the treatment for malignant gliomaChina Cancer J201322238240 Chinese
  • BrandesAABartolottiMFranceschiESecond surgery for recurrent glioblastoma: advantages and pitfallsExpert Rev Anticancer Ther20131358358723617349
  • ZhouLFYaoYYangSThe Stupp regimen preceded by early post-surgery temozolomide versus the Stupp regimen alone in the treatment of patients with newly diagnosed glioblastoma multiforme (GBM)J Clin Oncol20133115 Abstract 2022
  • ChakrabartiICockburnMCozenWWangYPPreston-MartinSA population-based description of glioblastoma multiforme in Los Angeles County, 1974–1999Cancer20051042798280616288487
  • StuppRMasonWPvan den BentMJRadiotherapy plus concomitant and adjuvant temozolomide for glioblastomaN Engl J Med200535298799615758009
  • YanYITangWYDengZXEfficacy of temozolomide in treatment of recurrent gliomaCancer Research on Prevention and Treatment20071713591364 Chinese
  • ReardonDAVredenburghJJDesjardinsAEffect of CYP3A-inducing anti-epileptics on sorafenib exposure: results of a phase II study of sorafenib plus daily temozolomide in adults with recurrent glioblastomaJ Neurooncol2011101576620443129
  • WangWThe treatment of elder patient with glioblastoma: a case reportPeople’s Military Surgeon20086369370 Chinese
  • Tianjin Tasly Group Co [homepage on the Internet]Chinaassociation of temozolomide Online Resources [updated August 16, 2012; cited August 9, 2013]. Available from: http://www.tasly.com/Accessed August 29, 2013
  • HongWQZhengGWangFSAdvances of temozolomide in the treatment of malignant gliomasChinese Journal of Neuro-oncology20086260264 Chinese
  • ShenDYangQYChenZPAdvances in the chemotherapy of malignant gliomas with temozolomideChinese Journal of Neuro-oncology20124271276 Chinese
  • WangXChenJXLiuYHMutant TP53 enhances the resistance of glioblastoma cells to temozolomide by up-regulating O(6)-methylguanine DNA-methyltransferaseNeurol Sci2013341421142823224642
  • BoultonSPembertonLCPorteousJKPotentiation of temozolomide-induced cytotoxicity: a comparative study of the biological effects of poly(ADP-ribose) polymerase inhibitorsBr J Cancer1995728498567547230
  • WuZChanCLEastmanABresnickEExpression of human O6-methylguanine-DNA methyltransferase in Chinese hamster ovary cells and restoration of cellular resistance to certain N-nitroso compoundsMol Carcinog199144824881793486
  • ZengXYangSClinical observation in chemotherapy with temozolomide alone in postoperative malignant primary cerebral gliomaMod J Neurol Neurosurg20033270273
  • QianZZWangHQLiuXMA multicenter randomized controlled study of temozolomide in 97 patients with malignant brain gliomaZhonghua Yi Xue Za Zhi20098920592062 Chinese20017331
  • JiYMXinLYangGKComparison of clinical effect between temozolomide and nimustine in patients with malignant gliomasChinese Journal of Cancer Prevention and Treatment20071410211022 Chinese
  • SunJYangXJYangSYMulticenter randomized controlled study of temozolomide versus semustine in the treatment of recurrent malignant gliomaZhonghua Yi Xue Za Zhi201393165168 Chinese23570586
  • GlasMHappoldCRiegerJLong-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomideJ Clin Oncol2009271257126119188676
  • HappoldCRothPWickWACNU-based chemotherapy for re- current glioma in the temozolomide eraJ Neurooncol200992454818987781
  • WickWHartmannCEngelCNOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomideJ Clin Oncol2009275874588019901110
  • YinAAZhangLHChengJXRadiotherapy plus concurrent or sequential temozolomide for glioblastoma in the elderly: a meta-analysisPLoS One20138e7424224086323
  • HartMGGrantRGarsideRTemozolomide for high grade gliomaCochrane Database Syst Rev20084CD00741518843749
  • LiangHDongSLEffectiveness and safety of postoperative radiotherapy plus temozolomide for treating brain malignant glioma in China: a meta-analysisModern Oncology20101823452348 Chinese
  • WangYWYinCLZhangZYMeta-analysis of temozolomide for high grade gliomasJ Shandong University2012508083 Chinese
  • ZhaoHXGaoLMFengWEffect of temozolomide plus radiotherapy in the treatment of glioblastomaHainan Medical Journal20122314 Chinese
  • XiaoPXLinKChaoSHRadiotherapy concomitant with temozolomide for glioblastoma multiformeChinese Journal of Neuro-oncology20054290295 Chinese
  • JinWWZhangHYWangYTThe clinical observation of temozolomide combined with intensity-modulated radiotherapy in the treatment of malignant glioma with positive MGMTJ Bengbu Med Coll2013385658 Chinese
  • StuppRHegiMEMasonWPEffects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialLancet Oncol20091045946619269895
  • KatohMNetworking of WNT, FGF, Notch, BMP, and Hedgehog signaling pathways during carcinogenesisStem Cell Rev20073303817873379
  • XieQXiGGongYProtease activated receptor-1 and brain edema formation in glioma modelsActa Neurochir Suppl201311819119423564130
  • HutchinsonLTargeted therapies: glioma – it’s all in the site occupancyNat Rev Clin Oncol2012930822508031
  • YangQYShenDSaiKNimotuzumab in combination with chemotherapy for patients with malignant gliomasZhonghua Zhong Liu Za Zhi201133232235 Chinese21575527
  • ChenXHZhouYXSunCMCombined modality therapy of recurrent gliomaJ Clin Neurosurg201298890
  • YangQYGuoCCSaiKPhase II trial of temozolomide plus interferon-β in recurrent malignant glioma patientsChinese Journal of Neuro-oncology201210234239 Chinese
  • TrottiAByhardtRStetzJCommon toxicity criteria: version 2.0. An improved reference for grading the acute effects of cancer treatment: impact on radiotherapyInt J Radiat Oncol Biol Phys200047134710758303
  • DarioATomeiGThe safety of temozolomide in patients with malignant gliomaCurr Drug Saf2006120522218690931
  • MinnitiGSalvatiMArcellaACorrelation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomideJ Neurooncol201110231131620686820
  • GerstnerEREichlerAFPlotkinSRPhase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomideJ Neurooncol201110332533220821342
  • ZhouBYMaoQWangPThe adverse effects analysis of temozolomide in glioma chemotherapyChinese Journal of Neuro-oncology2012101418 Chinese
  • LevatiLRuffiniFMuziAPlacenta growth factor induces melanoma resistance to temozolomide through a mechanism that involves the activation of the transcription factor NF-kappaBInt J Oncol20113824124721109946
  • LaiATranANghiemphuPLPhase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiformeJ Clin Oncol20112914214821135282
  • LiGYangQYGuoYExtended use of temozolomide for glioma patients based on MGMT expression pattern: experience of 32 casesChinese Journal of Neuro-oncology201210158165 Chinese
  • WangGXiaoHGuoLYRadiotherapy combined with temozolomide treatment for glioblastoma multiforme: a meta-analysisTumor20103010561065 Chinese
  • GeigerHSchleimerDNattamaiKJMutagenic potential of temozolomide in bone marrow cells in vivoBlood20061073010301116554488
  • GrewalJDellingerCAYungWKFatal reactivation of hepatitis B with temozolomideN Engl J Med20073561591159217429098
  • GoldbeckerATrycABRaabPHepatic encephalopathy after treatment with temozolomideJ Neurooncol201110316316620730617
  • KlepperBPaukerDMedicare’s drug plan: huge price disparities for common cancer drugsCommunity Oncol200637535511
  • CrottRThe economics of temozolomide in brain cancerExpert Opin Pharmacother200781923192917696793
  • WuBMiaoYBaiYSubgroup economic analysis for glioblastoma in a health resource-limited settingPLoS One20127e3458822511951
  • WangQWangNYShengHMClinical observation in temozolomide combined with radiotherapy in treatment of postoperative malignant gliomaChin J Cancer Prev Treat200815843845 Chinese
  • FuHWanLLYangLClinical study of temozolomide combined with radiotherapy in treatment of postoperative malignant gliomaChinese General Practice20111415561558 Chinese